Sean Whelan

This profile gathers the share dealings of Sean Whelan across 2 companies, led by Diplomat Pharmacy, Inc. and InfuSystem Holdings, Inc. We count 8 filings; the first trade dates from 6 May 2008 and the latest from 26 August 2015.

In open-market terms, that means 1 purchase worth €20k on one side and 2 sales worth €5.0M on the other. Sales outweigh purchases by €5.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 1 option exercise. In 2015 alone, the filings show no purchases and 2 sales.

Most recently, on 27 August 2015, the filings show an option exercise worth €1.1M in Diplomat Pharmacy, Inc. The last purchase on record was published on 10 October 2014, which is 4,413 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.